Literature DB >> 7487035

Characterization of a metalloprotease inhibitor protein (SmaPI) of Serratia marcescens.

K S Kim1, T U Kim, I J Kim, S M Byun, Y C Shin.   

Abstract

As suggested by Y. Suh and M.J. Benedik (J. Bacteriol. 174: 2361-2366, 1992), Serratia marcescens ATCC 27117 produced very small amounts (0.8 U ml-1) of an inhibitor protein (SmaPI) that shows an inhibitory activity against extracellular 50-kDa metalloprotease (SMP) of S. marcescens and that is localized in the periplasm of cells at the optimal growth temperature of 25 degrees C. A recombinant S. marcescens harboring plasmid pSP2 encoding SMP and SmaPI genes produced 20 U of SmaPI ml-1 that is also localized in the periplasm of cells at 25 degrees C. However, a large amount of SmaPI (86 Uml-1) was extracellularly produced at the supraoptimal growth temperature 37 degrees C from the recombinant S. marcescens (pSP2). We purified SmaPI from the culture supernatant of S. marcescens (pSP2) grown at 37 degrees C, and some biochemical properties were characterized. SmaPI had a pI value of about 10.0 and was a monomeric protein with a molecular mass of 10,000. SmaPI was produced from a precursor SmaPI by cleavage of a signal peptide (26 amino acid residues). The inhibitor was stable in boiling water for up to 30 min. The thermostability of SmaPI can be attributed to its reversible denaturation. SmaPI inhibited SMP by formation of a noncovalent complex with a molar ratio of 1:1 and showed a high protease specificity, which inhibited only SMP among the various proteases we examined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487035      PMCID: PMC167579          DOI: 10.1128/aem.61.8.3035-3041.1995

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  22 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Biosynthesis, processing, and evolution of bovine pancreatic trypsin inhibitor.

Authors:  T E Creighton; I G Charles
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

3.  A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides.

Authors:  D Perlman; H O Halvorson
Journal:  J Mol Biol       Date:  1983-06-25       Impact factor: 5.469

4.  Direct hybridization of labeled DNA to DNA in agarose gels.

Authors:  M Purrello; I Balazs
Journal:  Anal Biochem       Date:  1983-02-01       Impact factor: 3.365

5.  Purification and properties of a proteinaceous metallo-proteinase inhibitor from Streptomyces nigrescens TK-23.

Authors:  K Oda; T Koyama; S Murao
Journal:  Biochim Biophys Acta       Date:  1979-11-09

6.  Plasminostreptin, a protein proteinase inhibitor produced by Streptomyces antifibrinolyticus. III. Elucidation of the primary structure.

Authors:  H Sugino; A Kakinuma; S Iwanaga
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

Review 7.  Protein inhibitors of proteinases.

Authors:  M Laskowski; I Kato
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases.

Authors:  C H Chung; H E Ives; S Almeda; A L Goldberg
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Cloning and expression of a Bacillus coagulans amylase gene in Escherichia coli.

Authors:  P Cornelis; C Digneffe; K Willemot
Journal:  Mol Gen Genet       Date:  1982
View more
  2 in total

Review 1.  RTX proteins: a highly diverse family secreted by a common mechanism.

Authors:  Irena Linhartová; Ladislav Bumba; Jiří Mašín; Marek Basler; Radim Osička; Jana Kamanová; Kateřina Procházková; Irena Adkins; Jana Hejnová-Holubová; Lenka Sadílková; Jana Morová; Peter Sebo
Journal:  FEMS Microbiol Rev       Date:  2010-11       Impact factor: 16.408

2.  A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19.

Authors:  M Laura Darriba; Celeste Pueblas Castro; Lorena M Coria; Laura Bruno; M Laura Cerutti; Lisandro H Otero; Lucía B Chemes; Rodolfo M Rasia; Sebastián Klinke; Juliana Cassataro; Karina A Pasquevich
Journal:  Comput Struct Biotechnol J       Date:  2022-09-06       Impact factor: 6.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.